Highlights 2017

On 26 February, the AMYPAD initiative released its fourth external newsletter and reported what has been achieved during the first year of the project. The team was proud to look back at a lot of successful deliveries.

New paper featuring various AMYPAD members is out 03/11/2020 This personal view has been published in the journal The Lancet Neurology...

AMYPAD represented at #30AEC 04/11/2020 AMYPAD had a virtual booth at the 30th Alzheimer Europe Conference...

AMYPAD hosts a disclosure biomarker symposium 04/04/2022 The first presentation was delivered by Bruno Dubois who gave a keynote lecture on the changing definition of Alzheimer’s disease...

This project has received funding from the Innovative Medicines Initiative 2 Joint undertaking under grant agreement No 115952. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Acknowledgements, Legal Notice and Privacy Policy